Simple question......if it even had a chance....why would the French sell it to a no name in montreal?
Why wouldn't a real company assist this?
Why wouldnt a real company just buy them out?
Why won't a bank touch this HUGE potential drug?
Why did they reassign adva27a from advanomics to SBFM?
Why was it reassigned again to NOX pharma, a shell company?
Why have the patent fees not been paid in time? Leading to penalty fees?
Create an email that was supposedly from camille answering those questions. That's what legitimate investors wanna know. No answer to those, no help.
THERE IS NOTHING HERE, JUST THOSE TRYING TO GET THEIR MONEY BACK.
All IMO.
News 
Market Data 
Discover 
AI
